These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7238578)

  • 1. Biochemical mechanism of tolerance to neuroleptic drugs; regional differences in rat brain.
    Bacopoulos NG
    Eur J Pharmacol; 1981 Apr; 70(4):585-6. PubMed ID: 7238578
    [No Abstract]   [Full Text] [Related]  

  • 2. Homovanillic acid in caudate and pre-frontal cortex following acute and chronic neuroleptic administration.
    Bowers MB; Hoffman FJ
    Psychopharmacology (Berl); 1986; 88(1):63-5. PubMed ID: 2868484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic haloperidol on caudate 3H-spiroperidol binding in lesioned rats.
    Rosenblatt JE; Shore D; Neckers LM; Perlow MJ; Freed WJ; Wyatt RJ
    Eur J Pharmacol; 1979 Dec; 60(4):387-8. PubMed ID: 93551
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine receptors in rat frontal cortex: pharmacological properties in vivo and in vitro.
    Bacopoulos NG; Ware PL
    Life Sci; 1980 Dec 22-29; 27(25-26):2489-94. PubMed ID: 6163938
    [No Abstract]   [Full Text] [Related]  

  • 5. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
    Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain.
    Klemm N; Murrin LC; Kuhar MJ
    Brain Res; 1979 Jun; 169(1):1-9. PubMed ID: 455088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs.
    Laduron PM; Janssen PF; Leysen JE
    Biochem Pharmacol; 1978 Feb; 27(3):317-21. PubMed ID: 23127
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.
    Lee T; Seeman P; Tourtellotte WW; Farley IJ; Hornykeiwicz O
    Nature; 1978 Aug; 274(5674):897-900. PubMed ID: 683328
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis.
    Kurata K; Shibata R
    Pharmacology; 1991; 42(1):1-9. PubMed ID: 2057516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in dopaminergic receptors in Huntington's disease.
    Reisine TD; Fields JZ; Stern LZ; Johnson PC; Bird ED; Yamamura HI
    Life Sci; 1977 Oct; 21(8):1123-8. PubMed ID: 144230
    [No Abstract]   [Full Text] [Related]  

  • 12. Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration.
    Kurachi M; Shibata R; Murata M; Tanii Y
    Biol Psychiatry; 1995 Apr; 37(7):487-90. PubMed ID: 7786966
    [No Abstract]   [Full Text] [Related]  

  • 13. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
    Quik M; Spokes EG; Mackay AV; Bannister R
    J Neurol Sci; 1979 Nov; 43(3):429-37. PubMed ID: 521836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on some compensatory responses of dopaminergic system in aging rats.
    Algeri S; Achilli G; Cimino M; Perego C; Ponzio F; Vantini G
    Exp Brain Res; 1982; Suppl 5():146-52. PubMed ID: 7151906
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
    Howlett DR; Nahorski SR
    FEBS Lett; 1978 Mar; 87(1):152-6. PubMed ID: 631328
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional localization of halopemide, a new psychotropic agent, in the rat brain.
    Loonen AJ; van Wijngaarden I; Janssen PA; Soudijn W
    Eur J Pharmacol; 1978 Aug; 50(4):403-8. PubMed ID: 29759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala.
    Essig EC; Kilpatrick IC
    Psychopharmacology (Berl); 1991; 104(2):194-200. PubMed ID: 1876664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine metabolism, spiperone binding and adenylate cyclase activity in the adult rat hippocampus after ingrowth of dopaminergic neurones from embryonic implants.
    Bischoff S; Scatton B; Korf J
    Brain Res; 1979 Dec; 179(1):77-84. PubMed ID: 509234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.